1. A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
    Da Liu et al, 2019, Front. Pharmacol. CrossRef
  2. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
    Chaohe Zhang et al, 2020, Front. Pharmacol. CrossRef
  3. Berberine Hampers Influenza A Replication through Inhibition of MAPK/ERK Pathway
    Paweł Botwina et al, 2020, Viruses CrossRef
  4. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
    Jian Chen et al, 2020, Cancer Chemother Pharmacol CrossRef
  5. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway
    Xianxian Gao et al, 2021, Molecules CrossRef
  6. Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells
    Win Sen Heng et al, 2021, IJMS CrossRef
  7. Natural Compounds as Versatile Potential Therapeutic Agents of Lung Cancer
    Rabia Akram et al, 2021 CrossRef
  8. 9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity
    Jia-Ming Chang et al, 2021, IJMS CrossRef
  9. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
    Luying He et al, 2022, Front. Pharmacol. CrossRef
  10. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
    Yi Zhu et al, 2022, Front. Pharmacol. CrossRef
  11. Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
    Lulu Ni et al, 2022, Front. Pharmacol. CrossRef
  12. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
    Sajad Fakhri et al, 2022, Front. Oncol. CrossRef
  13. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
    Saabira Banu Sahubar Sadik et al, 2022 CrossRef
  14. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
    Ruo-Gu Xiong et al, 2022, Molecules CrossRef
  15. Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
    Bahram Bibak et al, 2022, CMC CrossRef
  16. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
    Saleh A. Almatroodi et al, 2022, Molecules CrossRef
  17. Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
    Ijeoma Theresa Achi et al, 2022, Cells CrossRef
  18. Berberine regulates pulmonary inflammatory microenvironment and decreases collagen deposition in response to bleomycin‐induced pulmonary fibrosis in mice
    Zheng Yang et al, 2022, Basic Clin Pharma Tox CrossRef
  19. Molecular and cellular aspects of the impact of secondary metabolites from common barberry and hybrid goat’s rue on the HeLa cell line
    E. Yu. Zlatnik et al, 2023, Issled. prakt. med. (Print) CrossRef
  20. Oxyepiberberine from the Active Site of Coptidis Rhizoma Inhibits Lung Adenocarcinoma by Regulating SRC-related Pathways in vivo
    Ying Zhang et al, 2024, Pharmacognosy Magazine CrossRef
  21. Therapeutic Effects of Berberine against Urological Cancers: Biological Potentials Based on Cellular Mechanisms
    Ali Bozorg Savoji et al, 2024, CMM CrossRef
  22. Transplant oncology and anti-cancer immunosuppressants
    Dejun Kong et al, 2025, Front. Immunol. CrossRef